1. Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study. Issue 1 (January 2021) Authors: Tan, Antoinette R; Im, Seock-Ah; Mattar, André; Colomer, Ramon; Stroyakovskii, Daniil; Nowecki, Zbigniew; De Laurentiis, Michelino; Pierga, Jean-Yves; Jung, Kyung Hae; Schem, Christian; Hogea, Alexandra; Badovinac Crnjevic, Tanja; Heeson, Sarah; Shivhare, Mahesh; Kirschbrown, Whitney P; Restuccia... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Junctophilin‐4 facilitates inflammatory signalling at plasma membrane‐endoplasmic reticulum junctions in sensory neurons. (3rd March 2021) Authors: Hogea, Alexandra; Shah, Shihab; Jones, Frederick; Carver, Chase M.; Hao, Han; Liang, Ce; Huang, Dongyang; Du, Xiaona; Gamper, Nikita Journal: Journal of physiology Issue: Volume 599:Number 7(2021) Page Start: 2103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p. Issue 1 (December 2017) Authors: Berrout, Jonathan; Kyriakopoulou, Eleni; Moparthi, Lavanya; Hogea, Alexandra; Berrout, Liza; Ivan, Cristina; Lorger, Mihaela; Boyle, John; Peers, Chris; Muench, Stephen; Gomez, Jacobo; Hu, Xin; Hurst, Carolyn; Hall, Thomas; Umamaheswaran, Sujanitha; Wesley, Laura; Gagea, Mihai; Shires, Michael; M... Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗